BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 2.15 Delayed Data As of Mar 24 |  -0.07 / -3.15%Today’s Change | 2.03 Today|||52-Week Range 22.90 | -27.36% Year-to-Date |
Latest BVXV News | Press Releases
No recent news for BiondVax Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 2.22 |
| Today’s open | 2.17 |
| Day’s range | 2.15 - 2.17 |
| Volume | 142 |
| Average volume (3 months) | 122,191 |
| Market cap | $4.0M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -650.17% |
| Earnings growth (this year) | -1,380.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LMLLFPharmadrug Inc | 0.00 | 0.00% |
| ---- | ||
| --Eve & Co Inc | 0.00 | 0.00% |
| CYANCyanotech Corp | 0.00 | 0.00% |
Data as of 1:20pm ET, 03/23/2023
Financials
| Next reporting date | May 2, 2023 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
